IRX3 variant as a modifier of Brugada syndrome with frequent ventricular fibrillation  Yoshitaka Kimura, MD, Takeshi Aiba, MD, PhD, Tetsuo Sasano, MD,

Slides:



Advertisements
Similar presentations
Kuan-Rau Chiou, MD, Chien-Tung Chu, MD, Min-Ji Charng, MD, PhD 
Advertisements

Volume 9, Issue 1, Pages (January 2012)
Volume 9, Issue 7, Pages (July 2012)
Volume 9, Issue 7, Pages (July 2012)
Ellis Rochelson, MD, Lynn Nappo, RN, Robert H. Pass, MD 
Ali Sazci, Ph. D. , Nesrin Ercelen, M. D. , Emel Ergul, M. S
The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome  Samuel D. Quaynor, M.S., Hyung-Goo.
Volume 11, Issue 1, Pages (January 2014)
Atrioventricular hysteresis pacemaker mode promoting a short-long-short sequence at the onset of ventricular tachycardia  Neiberg de Alcantara Lima, MD,
Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome  Yasuaki.
A subtype of idiopathic ventricular fibrillation and its relevance to catheter ablation and genetic variants  Takahiko Nishiyama, MD, Yoshiyasu Aizawa,
Genotype-phenotype-guided medical and surgical intervention in long QT syndrome  Robyn J. Hylind, MS, CGC, Virginie Beausejour Ladouceur, MD, Francis Fynn-Thompson,
Correlation between functional and ultrastructural substrate in Brugada syndrome  Pablo E. Tauber, MD, Virginia Mansilla, MD, Guillermo Mercau, MD, Felix.
Is it bradycardia or something else causing symptoms?
Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome  Laura Halperin, BSc, Greg Mellor, MD, Mario.
Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3- specific calmodulinopathy  Marie-A. Chaix, MD, MSc, Tamara T. Koopmann, PhD,
T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome 
Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.
HeartRhythm Case Reports
Is variant pathogenicity in the eye of the beholder
Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart  Hoang H. Nguyen, MD, Dorothy K. Grange, MD,
Local activation delay exacerbates local J-ST elevation in the epicardium: Electrophysiological substrate in Brugada syndrome  Naoya Kataoka, MD, PhD,
Repeated molecular genetic analysis in Brugada syndrome revealed a novel disease- associated large deletion in the SCN5A gene  Anders Krogh Broendberg,
Atrial pacing for the management of ventricular arrhythmias in Andersen-Tawil syndrome  Opeyemi Fadahunsi, MBBS, MPH, Bilal Shaikh, DO, Andrew Rettew,
Jonathan T. Jaffe, MD, Lee-Gardie Jean, MD, Richard J. Murray, MD 
Failure of ICD therapy in lethal arrhythmogenic right ventricular cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu mutation  Kasper Aalbæk Kjærgaard,
Parasternal intercostal approach as an alternative to subxiphoid approach for epicardial catheter ablation: A case report  Koji Miyamoto, MD, Takashi.
HeartRhythm Case Reports
Low room temperature can trigger ventricular fibrillation in J wave syndromes  Masaru Yamaki, MD, Nobuyuki Sato, MD, PhD, Rina Imanishi, MD, Hirotsuka.
Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy  Jayaprakash.
Beauty and the beat: A complicated case of multifocal ectopic Purkinje-related premature contractions  Rachel M.A. ter Bekke, MD, PhD, Miren David, BSc,
A large familial pathogenic Plakophilin-2 gene (PKP2) deletion manifesting with sudden cardiac death and lone atrial fibrillation: Evidence for alternating.
Kevin M. W. Leong, MBBS, MRCP, Henry Seligman, MBBS, MRCP, Amanda M
Recording of isolated very delayed potentials on the right ventricular epicardium in a patient with Brugada syndrome  Atsuyuki Watanabe, MD, Hiroshi Morita,
Expanding the electrical phenotype of NKX2-5 mutations: Ventricular tachycardia, atrial fibrillation, and complete heart block within one family  Simone.
Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome  Shaobo Shi, MD, PhD, Tao Liu, MD, PhD,
Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing  Samuel Chauveau, MD, Alexandre Janin, PharmD,
Simrit K. Warring, MS, Heather N. Anderson, MD, J
Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death  Johnni Rudbeck-Resdal, MD, Jens.
Ankyrin-2 variants associated with idiopathic ventricular fibrillation storm in patients with intermittent early repolarization pattern  Anders Krogh.
Jay A. Montgomery, MD, Dan M. Roden, MD, FHRS  HeartRhythm Case Reports 
Vagally mediated ventricular arrhythmia in Brugada syndrome
A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation 
Volume 6, Issue 3, Pages (March 2009)
Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular.
Mitral valve repair results in suppression of ventricular arrhythmias and normalization of repolarization abnormalities in mitral valve prolapse  Wael.
Successful catheter ablation of idiopathic ventricular tachycardia originating from the top of the left ventricular posterior papillary muscle near the.
Long-term follow-up of permanent atrial standstill in a German family with mutation in the SCN5A gene  H. Immo Lehmann, MD, Ulf Meltendorf, MD, Helmut.
Successful implantation of a subcutaneous cardiac defibrillator in a patient with a preexisting deep brain stimulator  Yousef Bader, MD, Jonathan Weinstock,
Justin D. Smith, MD, Jeffrey M. Vinocur, MD  HeartRhythm Case Reports 
Volume 9, Issue 1, Pages (January 2012)
Even pore-localizing missense variants at highly conserved sites in KCNQ1-encoded Kv7.1 channels may have wild-type function and not cause type 1 long.
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators  Thor Tejada, MD, Faisal.
Different rate-dependent responses between J waves and the notches on an epicardial local electrogram in a patient with idiopathic ventricular fibrillation 
A novel ACTC1 mutation in a young boy with left ventricular noncompaction and arrhythmias  Yoko Yoshida, MD, Keiichi Hirono, MD, PhD, Kae Nakamura, MD,
Impact of a novel algorithm designed to reduce T-wave oversensing with the subcutaneous defibrillator in a patient with type I Brugada electrocardiogram 
Short QT and atrial fibrillation: A KCNQ1 mutation–specific disease
The use of noninvasive ECG imaging for examination of a patient with Brugada syndrome  Maria Chaykovskaya, MD, Boris Rudic, MD, Alexey Tsyganov, MD, Elena.
Colin Yeo, MBBS, Martin Green, MD, Robert Lemery, MD, FHRS 
Radiofrequency catheter ablation for treatment of premature ventricular contractions triggering ventricular fibrillation from the right ventricular outflow.
Polygenic case of long QT syndrome confirmed through functional characterization informs the interpretation of genetic screening results  Malcolm Hoshi,
Annika Winbo, MD, PhD, Annika Rydberg, MD, PhD 
Unusual severe hemodynamic failure associated with standard dose of intravenous flecainide for pharmacological cardioversion of atrial fibrillation  Aref.
Quinidine for Brugada syndrome: Panacea or poison?
Abdul R. Mourad, MD, Michael H. Kim, MD, FHRS, Malcolm M
Early repolarization syndrome: A case report focusing on dynamic electrocardiographic changes before ventricular arrhythmias and genetic analysis  Vern.
Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.
Ablation of a symptomatic spontaneous automatic focus arising from an atriofascicular fiber  Sandrine Venier, MD, Paul Khairy, MD, PhD, Bernard Thibault,
Volume 6, Issue 9, Pages (September 2009)
HeartRhythm Case Reports
Presentation transcript:

IRX3 variant as a modifier of Brugada syndrome with frequent ventricular fibrillation  Yoshitaka Kimura, MD, Takeshi Aiba, MD, PhD, Tetsuo Sasano, MD, PhD, Tetsushi Furukawa, MD, PhD, Kengo Kusano, MD, PhD, Wataru Shimizu, MD, PhD  HeartRhythm Case Reports  Volume 2, Issue 6, Pages 465-468 (November 2016) DOI: 10.1016/j.hrcr.2016.06.002 Copyright © 2016 Heart Rhythm Society Terms and Conditions

Figure 1 A: Surface electrocardiogram (ECG) of the proband in the fourth and the third intercostal spaces (ICS). ECG showed coved-type ST elevation in V1 and V2 (arrows), which was more pronounced in the third ICS than the fourth ICS. B: Monitor ECG of a spontaneous occurrence of ventricular fibrillation (VF) in the proband. Premature ventricular complexes developed immediately before the occurrence of VF. C: Family pedigree of Brugada syndrome patient with the SCN5A A735V mutation. In those with available ECG recordings, V1- and V2-lead ECGs are shown. Arrows: proband. Square: male subjects; circle: female subjects. HeartRhythm Case Reports 2016 2, 465-468DOI: (10.1016/j.hrcr.2016.06.002) Copyright © 2016 Heart Rhythm Society Terms and Conditions

Figure 2 A: DNA sequence analysis results of the proband. The arrow indicates a heterozygous variant in the IRX3 gene (Q479H). B: Homology of human IRX3 and murine Irx3. Amino acids sequence conserved between human IRX3 and mouse Irx3 was highly conserved between human IRX3 and mouse Irx3. C: Effects of transfection of HL-1 cells with Irx3 in pcDNA3.1 vector on the expression of SCN5A. The expression of SCN5A was normalized to that of Irx3. Wild-type Irx3 increased the mRNA expression of SCN5A, whereas Irx3-Q485H (human Q479H) did not increase the SCN5A mRNA expression. *P < .05 vs control. HeartRhythm Case Reports 2016 2, 465-468DOI: (10.1016/j.hrcr.2016.06.002) Copyright © 2016 Heart Rhythm Society Terms and Conditions